ConductScience.org, home

Paper3978049

Reduced killer cell activity of lymphocytes from patients with asbestosis.

Kubota M and 3 others. Br J Ind Med, 1985. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Reduced killer cell activity of lymphocytes from patients with asbestosis. Papers, record 3978049. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3978049

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reduced killer cell activity of lymphocytes from patients with asbestosis.
PubMed
Journal
Br J Ind Med
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.96
iCite
Revised in PubMed
2019-05-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kubota MM
2Kagamimori SS
3Yokoyama KK
4Okada AA

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AsbestosisMajor topic
Killer Cells, NaturalMajor topic
Adult
Aged
Antibody-Dependent Cell Cytotoxicity
Cytotoxicity, Immunologic
Female
Humans
Interferon Type I
Male
Middle Aged
Textile Industry

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113782506Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.Br J Ind Med1960https://conductscience.org/library/papers/13782506PubMed
2301449Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity.Clin Exp Immunol1977https://conductscience.org/library/papers/301449PubMed
3650156
Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis.
J Exp Med1978https://conductscience.org/library/papers/650156PubMed
44548939Immunology and asbestosis.Proc R Soc Med1973https://conductscience.org/library/papers/4548939PubMed
56175456Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.Clin Exp Immunol1981https://conductscience.org/library/papers/6175456PubMed
66165267Dual mechanism of interferon augmentation of natural killer cytotoxicity (NKCC).Ann N Y Acad Sci1980https://conductscience.org/library/papers/6165267PubMed
76180109The interferon system in patients with malignant disease.J Interferon Res1982https://conductscience.org/library/papers/6180109PubMed
86219848Natural killer (NK) cells and their possible roles in resistance against disease.Clin Immunol Rev1981https://conductscience.org/library/papers/6219848PubMed
9153888Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.Immunol Rev1979https://conductscience.org/library/papers/153888PubMed
106179500Lack of correlation between impaired interferon production and natural killer activity of lymphocytes in multiple sclerosis.Arch Virol1982https://conductscience.org/library/papers/6179500PubMed
116170674Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease.J Immunol1981https://conductscience.org/library/papers/6170674PubMed
12648028Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma.Clin Exp Immunol1978https://conductscience.org/library/papers/648028PubMed
137418675An epidemiological survey of immunological abnormalities in asbestos workers. II. Serum immunoglobulin levels.Environ Res1980https://conductscience.org/library/papers/7418675PubMed
1480299Natural killer cells in the mouse: an alternative immune surveillance mechanism?Contemp Top Immunobiol1978https://conductscience.org/library/papers/80299PubMed
154620331Biological effects of ingested asbestos: report and commentary.Environ Health Perspect1974https://conductscience.org/library/papers/4620331PubMed
16310826Augmentation of mouse natural killer cell activity by interferon and interferon inducers.J Immunol1979https://conductscience.org/library/papers/310826PubMed
17872451Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity.Clin Exp Immunol1977https://conductscience.org/library/papers/872451PubMed
1813998252Experimental production of mesothelial tumours of the pleura by implantation of dusts in laboratory animals.Nature1962https://conductscience.org/library/papers/13998252PubMed
196968265An epidemiological survey of immunological abnormalities in asbestos workers. I. Nonorgan and organ-specific autoantibodies.Environ Res1980https://conductscience.org/library/papers/6968265PubMed
206817954Natural killer cells and interferon responses in patients with systemic lupus erythematosus.Clin Exp Immunol1982https://conductscience.org/library/papers/6817954PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
9539011Selected new developments in asbestos immunotoxicity.Environ Health Perspect1998https://conductscience.org/library/papers/9539011PubMed
3260800Immune response in shipyard workers with x ray abnormalities consistent with asbestos exposure.Br J Ind Med1988https://conductscience.org/library/papers/3260800PubMed
2649672Malignant mesothelioma.J R Soc Med1989https://conductscience.org/library/papers/2649672PubMed
2424930High frequency of immune dysfunctions in asbestos workers and in patients with malignant mesothelioma.J Clin Immunol1986https://conductscience.org/library/papers/2424930PubMed
1846329Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma.Clin Exp Immunol1991https://conductscience.org/library/papers/1846329PubMed
1463684Lymphocyte subsets in subjects exposed to asbestos: changes in circulating natural killer cells.Br J Ind Med1992https://conductscience.org/library/papers/1463684PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3978049

GET https://conductscience.org/api/papers/v1/3978049/authors